1. Home
  2. PRQR

PRQR

ProQR Therapeutics N.V.

Logo ProQR Therapeutics N.V.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Founded: 2012 Country:
Netherlands
Netherlands
Employees: N/A City: N/A
Market Cap: 161.9M IPO Year: 2014
Target Price: $4.00 AVG Volume (30 days): 224.7K
Analyst Decision: Buy Number of Analysts: 6
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.37 EPS Growth: N/A
52 Week Low/High: $1.11 - $3.29 Next Earning Date: 05-14-2024
Revenue: $10,583,333 Revenue Growth: 118.51%
Revenue Growth (this year): 55.81% Revenue Growth (next year): 60.95%

Share on Social Networks: